November 20th, 2024Program Wednesday

Congress hall
08:30–09:45 am

Improving stroke outcome


Chair: Tadeusz Wieloch

Conference room 214
08:30–09:45 am

Inflammation and the brain 2: therapeutic approaches


Chair: Johannes Boltze, Servio Ramirez

Meeting room 215
08:30–09:45 am

Novel concepts for optimization of therapeutic approaches


Chair: Christoph Harms

09:45-10:15 am | Coffee break

Congress hall
10:15–11:45 am

Tissue-type Plasminogen Activator (tPA): Beyond Fibrinolysis


Chair: Nikolaus Plesnila, Denis Vivien

Conference room 214
10:15–11:45 am

Neuroprotection and immunomodulation for stroke in post-thrombectomy era


Chair: Piotr Walzcak, Raphael Guzman

Meeting room 215
10:15–11:45 am

Hemorrhagic stroke I: Novel therapeutic approaches


Chair: Kunjan R. Dave, Ann Stowe

11:45-12:30 pm | Lunch break
12:30–01:30 pm | Poster viewing

Congress hall
01:30–03:00 pm

Defining a role for the immune system in stroke: preclinical and clinical evidence


Chair: Mathias Gelderblom, Stuart Allan

Conference room 214
01:30–03:00 pm

Mesenchymal Stem Cell-derived Extracellular Vesicles: a Potential New Tool for Cerebral Ischemia


Chair: Aurel Popa–Wagner, Dirk Hermann

Meeting room 215
01:30–03:00 pm

Hemorrhagic stroke II: novel models and mechanisms


Chair: Teresa Gasull, Catherine Lawrence

Congress hall
03:10–04:00 pm

ISN&N closing session


Chair: Johannes Boltze, Nikolaus Plesnila

Status: Nov 2024